Clinical trial
Biomarker Analyses in Hepatocellular Carcinoma Patients Treated With Therasphere®
NCT03203837 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biomarker Analyses in Hepatocellular Carcinoma Patients Treated With Therasphere®
- Lead sponsor
- Northwestern University
- Phase
- Observational
- Overall status
- Terminated
- Start date
- July 5, 2017
- Completion date
- January 6, 2020
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma